Role of inhibitor of yes‐associated protein 1 in triple‐negative breast cancer with taxol‐based chemoresistance

Triple‐negative breast cancer (TNBC) is highly clinically aggressive and taxol‐based chemoresistance remains a big TNBC therapeutic problem to be solved. Verteporfin, a small molecular yes‐associated protein 1 (YAP1) inhibitor, is little known as an antitumor drug for TNBC. Our data showed that YAP1...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Wang, Shunan, Wei, Xi, Zhang, Sheng, Song, Zian, Chen, Xiao, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361558/
https://www.ncbi.nlm.nih.gov/pubmed/30467925
http://dx.doi.org/10.1111/cas.13888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361558/
https://www.ncbi.nlm.nih.gov/pubmed/30467925
http://dx.doi.org/10.1111/cas.13888

Ejemplares similares